Definitive Contract 75F40122C00192
Award Date
9/22/22
Potential Completion Date
9/28/25
Potential Value
$3M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
165
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,999,953.00, was granted to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte), a non-profit collaboration of academia, industry, and other stakeholders that conducts research and education to advance pharmaceutical technology. The contract was awarded by the Food and Drug Administration (FDA) through its Broad Agency Announcement mechanism to support research and development on a model-based systems engineering approach...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $743,717.94 Definitive Contract to the National Institute For Pharmaceutical Technology & Education Inc. (Nipte), a non-profit organization, to conduct research and development on the assessment of smoking and vaping risk of opioids and commercial products, as well as the standardization of methods to assess these properties. This contract was issued under the FDA's Broad Agency Announcement...
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
The U.S. Food and Drug Administration (FDA) awarded a $901,888.19 definitive contract to the National Academy of Sciences (NAS), a non-profit organization, to produce a consensus report that identifies innovative technologies to advance pharmaceutical manufacturing. The contract, which is not set aside, was awarded on July 19, 2019 with a completion date of March 31, 2022. The report will assist the FDA's Center for Drug Evaluation and Research (CDER) in fostering the adoption of innovative...
This federal contract award, with a ceiling value of $1,927,163.66, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The contract was awarded to SRI International, a non-profit research and development organization, and is part of NIDA's Pharmacology and Toxicology for Neurotherapeutics Program (PTNP). The contract, which is a Delivery Order under the PTNP Indefinite Delivery Vehicle (IDV), is for IND-enabling studies....
The Food and Drug Administration (FDA) awarded a $248,553.46 firm fixed price contract to the Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to develop modernized susceptibility guidance for the antibiotic nitrofurantoin using a dynamic urinary tract in vitro infection model and pharmacometric approaches. This contract was awarded under the FDA's Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. The BAA...
This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Research Triangle Institute (RTI International), a non-profit research organization. The contract is for the "Preparation and Distribution of Research Drug Products" and has a period of performance from March 20, 2025 to March 19, 2029, with a ceiling value of $1,497,865.00. The contract type is Delivery Order with a Cost Plus Fixed Fee pricing structure. The contract does not...
This federal contract award to The Trustees of Princeton University, valued at $2,692,771.30, is for an Integrated Platform for Continuous RNA Nanoparticle Formulation and Drying. The award was made by the Food and Drug Administration (FDA) and is not associated with a set-aside program. The contract supports research and development to advance regulatory science in areas of interest to the FDA, as outlined in a Broad Agency Announcement (BAA) solicitation. Key subcontractors include Seran...
This is a federal contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Research Triangle Institute (RTI International), a non-profit research organization. The contract, awarded on September 7, 2016, has a ceiling value of $446,542.08 and a period of performance ending on September 30, 2018. The contract was a Blanket Purchase Agreement (BPA) call under the Mission Oriented Business Integrated Services (MOBIS) GSA Schedule, indicating RTI International will provide a...